Mary Dibiase - Net Worth and Insider Trading

Mary Dibiase Net Worth

The estimated net worth of Mary Dibiase is at least $179,502 dollars as of 2025-03-05. Mary Dibiase is the COO of X4 Pharmaceuticals Inc and owns about 490,980 shares of X4 Pharmaceuticals Inc (XFOR) stock worth over $179,502. Details can be seen in Mary Dibiase's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mary Dibiase has not made any transactions after 2025-01-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Mary Dibiase

To

Mary Dibiase Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mary Dibiase owns 1 companies in total, including X4 Pharmaceuticals Inc (XFOR) .

Click here to see the complete history of Mary Dibiase’s form 4 insider trades.

Insider Ownership Summary of Mary Dibiase

Ticker Comapny Transaction Date Type of Owner
XFOR X4 Pharmaceuticals Inc 2025-01-24 Chief Operating Officer

Mary Dibiase Latest Holdings Summary

Mary Dibiase currently owns a total of 1 stock. Mary Dibiase owns 490,980 shares of X4 Pharmaceuticals Inc (XFOR) as of January 24, 2025, with a value of $179,502.

Latest Holdings of Mary Dibiase

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
XFOR X4 Pharmaceuticals Inc 2025-01-24 490,980 0.37 179,502

Holding Weightings of Mary Dibiase


Mary Dibiase Form 4 Trading Tracker

According to the SEC Form 4 filings, Mary Dibiase has made a total of 11 transactions in X4 Pharmaceuticals Inc (XFOR) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in X4 Pharmaceuticals Inc is the sale of 22,258 shares on January 24, 2025, which brought Mary Dibiase around $10,016.

Insider Trading History of Mary Dibiase

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mary Dibiase Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Mary Dibiase Ownership Network

Ownership Network List of Mary Dibiase

No Data

Ownership Network Relation of Mary Dibiase

Insider Network Chart

Mary Dibiase Owned Company Details

What does X4 Pharmaceuticals Inc do?

Who are the key executives at X4 Pharmaceuticals Inc?

Mary Dibiase is the Chief Operating Officer of X4 Pharmaceuticals Inc. Other key executives at X4 Pharmaceuticals Inc include See Remarks Adam S. Mostafa , director & President and CEO Paula Ragan , and Chief Medical Officer Christophe Arbet-engels .

X4 Pharmaceuticals Inc (XFOR) Insider Trades Summary

Over the past 18 months, Mary Dibiase made 7 insider transaction in X4 Pharmaceuticals Inc (XFOR) with a net sale of 182,024. Other recent insider transactions involving X4 Pharmaceuticals Inc (XFOR) include a net sale of 690,513 shares made by Paula Ragan , a net sale of 616,284 shares made by Adam S. Mostafa , and a net sale of 159,637 shares made by Arthur Taveras .

In summary, during the past 3 months, insiders sold 214,287 shares of X4 Pharmaceuticals Inc (XFOR) in total and bought 0 shares, with a net sale of 214,287 shares. During the past 18 months, 1,710,625 shares of X4 Pharmaceuticals Inc (XFOR) were sold and 35,050 shares were bought by its insiders, resulting in a net sale of 1,675,575 shares.

X4 Pharmaceuticals Inc (XFOR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

X4 Pharmaceuticals Inc Insider Transactions

No Available Data

Mary Dibiase Mailing Address

Above is the net worth, insider trading, and ownership report for Mary Dibiase. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Mary Dibiase's mailing address is: Boston Ma 02134.